On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest findings and … Article

February 7, 2022
IMBCR & Emory University’s Big Discovery!!!
Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, … Article

February 6, 2022
James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center
New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative
LOS ANGELES, Nov. 11, … Article
February 8, 2022
0 Comments